The study sample was comprised of postmenopausal women with hormone receptor positive, early‐stage breast cancer who were primarily Caucasian; the generalizability of study findings to premenopausal women, hormone negative, in situ and more advanced breast cancers, or more diverse populations is unknown. Here, NR4A1 is linked to breast carcinoma.